A Cross Sectional Study to Assess the Levels of Depression and Anxiety in Patients with Chronic Obstruction Pulmonary Disease in a Tertiary Care Hospital
DOI:
https://doi.org/10.21276/mbqf7197Keywords:
COPD, DepressionAbstract
Background: Objective: In the present study, demographic profile, knowledge and motivation of COPD patients attending tertiary hospital, the level of anxiety and depression is assessed. Methods: This cross-sectional study was carried out on consecutive patients with COPD during their routine out-and in-patient visits in the tertiary care hospital during 4 months (April 2019 to July 2019). Physician confirmed cases of more than 1-year duration were included in the study. Thus 194 COPD patients were admitted in the ward. They were interviewed by using HADS scale and Modified Morisky scale. The diagnosis of COPD was confirmed by Chest X-ray and Spirometery test and a history of exacerbation or hospitalization over past 6 months was also obtained. The chi square-test, t-test and one-way analysis of variance were used in the univariate analyses, whilst regression was used in the multiple variable analyses.
Results: A total of 194 COPD individuals, 124 Males and 70 Females were enrolled in the study. The mean age of the respondents was 49.16 ± 8.20 (25-62) years. The mean scores for anxiety and depression were 19.12± 2.38 and 11.54± 2.50 respectively. Both anxiety and depression scores were statistically significant between the gender. Among males 70 % cases were having no comorbid conditions; however, 57.10 % females were having more than two comorbid conditions.
Conclusion: Present study illustrates that anxiety and depression are common in patients with COPD, furthermore, patients with depressive disorders have more comorbidities in comparison with patient with anxiety.
Downloads
References
World Health Organisation. Chronic obstructive pulmonary disease
(COPD).2017. Available from https://www.who.int/news-room/factsheets/detail/chronic-obstructive-pulmonary-disease-(copd). [Last
Accessed on 20 feb, 2021]
Global Initiative for Chronic Obstructive Lung Disease -GOLD
Guideline: Global Strategy for the Diagnosis, Treatment, and
Prevention of Chronic Obstructive Pulmonary Disease. 2011. Available
from: http://www.goldcopd.com. [Last Accessed on 20 Feb2021]
GBD 2015 Chronic Respiratory Disease Collaborators. Global,
regional, and national deaths, prevalence, disability-adjusted life years,
and years lived with disability for chronic obstructive pulmonary disease
and asthma, 1990–2015: a systematic analysis for the Global
Burden of Disease Study 2015. The Lancet. Respiratory Medicine.
;5(9):691-706.
India State-Level Disease Burden Initiative Collaborators. Nations
within a nation: variations in epidemiological transition across the states
of India, 1990-2016 in the Global Burden of Disease Study. Lancet.
;390(10111):2437-2460. doi: 10.1016/S0140-6736(17)32804-0.
Epub 2017 Nov 14. Erratum in: Lancet. 2017 Dec 2;390(10111):e49.
PMID: 29150201; PMCID: PMC5720596.[PubMed].
ICMR, PHFI, IHME. India: Health of the Nation’s States—The India statelevel disease burden initiative. New Delhi: Indian Council of Medical
Research, Public Health Foundation of India, Institute for Health metrics
and Evaluation, 2017.
Global, regional, and national deaths, prevalence, disability-adjusted
life years, and years lived with disability for chronic obstructive
pulmonary disease and asthma, 1990-2015: a systematic analysis
for the Global Burden of Disease Study 2015. Lancet Respir Med.
;5(9):691-706. Available from:https://doi.org/10.1016/S2213-
(17)30293-X
Cruz AA. Global surveillance, prevention and control of chronic respiratory
diseases: a comprehensive approach. World Health Organization;
Available
from:https://www.who.int/gard/publications/GARD_Manual/en/[last
access on 16mar 2021]
ICMR PI, PHFI I. India: health of the nation’s states: the india state-level
disease burden initiative. New Delhi, India. 2017.
Mathers CD, Loncar D. Projections of global mortality and burden
of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
doi: 10.1371/journal.pmed.0030442. PMID: 17132052; PMCID:
PMC1664601.[PubMed].
Yohannes AM. Palliative care provision for patients with chronic
obstructive pulmonary disease. Health Qual Life Outcomes.
;5:17. doi: 10.1186/1477-7525-5-17. PMID: 17407591; PMCID:
PMC1852092.[PubMed].
Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive
symptoms and chronic obstructive pulmonary disease: effect on
mortality, hospital readmission, symptom burden, functional status,
and quality of life. Arch Intern Med. 2007;167(1):60-7. doi:
1001/archinte.167.1.60. PMID: 17210879.[PubMed].
Peveler R, Carson A, Rodin G. Depression in medical patients. BMJ.
;325(7356):149-52. doi: 10.1136/bmj.325.7356.149. PMID:
; PMCID: PMC1123674.[PubMed].
Bentsen SB, Miaskowski C, Rustøen T. Demographic and clinical
characteristics associated with quality of life in patients with chronic
obstructive pulmonary disease. Qual Life Res. 2014;23(3):991-
doi: 10.1007/s11136-013-0515-5. Epub 2013 Sep 3. PMID:
[PubMed].
Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F,
Allegra L, Centanni S. Anxiety and depression in COPD patients: The
roles of gender and disease severity. Respir Med. 2006;100(10):1767-74.
doi: 10.1016/j.rmed.2006.01.026. Epub 2006 Mar 13. PMID:
[PubMed]
Eckerblad J, Tödt K, Jakobsson P, Unosson M, Skargren E, Kentsson
M, Theander K. Symptom burden in stable COPD patients with
moderate or severe airflow limitation. Heart & Lung. 2014;43(4):351-
Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP,
Stanley MA. Surprisingly high prevalence of anxiety and depression
in chronic breathing disorders. Chest. 2005;127(4):1205-11. doi:
1378/chest.127.4.1205. PMID: 15821196.[PubMed].
Reinke LF, Slatore CG, Udris EM, Moss BR, Johnson EA, Au DH. The
association of depression and preferences for life-sustaining
treatments in veterans with chronic obstructive pulmonary disease. J
Pain Symptom Manage. 2011;41(2):402-11. doi:
1016/j.jpainsymman.2010.05.012. Epub 2010 Dec 8. PMID:
[PubMed]
Walke LM, Byers AL, Tinetti ME, Dubin JA, McCorkle R, Fried TR. Range
and severity of symptoms over time among older adults with chronic
obstrucive pulmonary disease and heart failure. Arch Intern Med.
;167(22):2503-8. doi: 10.1001/archinte.167.22.2503. PMID:
; PMCID: PMC2196402.[PubMed].
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients
with end stage chronic obstructive pulmonary disease (COPD)? A
comparison of palliative care and quality of life in COPD and lung
cancer. Thorax. 2000;55(12):1000-6. doi: 10.1136/thorax.55.12.1000.
PMID: 11083884; PMCID: PMC1745647.[PubMed].
Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients
with COPD psychologically distressed? Eur Respir J. 2005;26(2):242-
doi: 10.1183/09031936.05.00010604. PMID: 16055871.[PubMed].
McCathieHC, Spence SH, Tate RL. Adjustment to chronic obstructive
pulmonary disease: the importance of psychological factors. Eur
Respir J. 2002;19(1):47-53. doi: 10.1183/09031936.02.00240702.
PMID: 11852894.[PubMed].
Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional
associations between clinically relevant depression or anxiety and
COPD: a systematic review and meta-analysis. Chest.
;144(3):766-777. doi: 10.1378/chest.12-1911. PMID:
[PubMed].
Zigmond AS, Snaith RP. The hospital anxiety and depression scale.
Acta Psychiatr Scand. 1983;67(6):361-70. doi: 10.1111/j.1600-
1983.tb09716.x. PMID: 6880820.[PubMed]
Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea.
Chest. 1988;93(3):580-6. doi: 10.1378/chest.93.3.580. PMID:
[PubMed]
Vural B, Acar ÖT, Topsever P, Filiz TM. Reliability and validity of Turkish
version of modified Morisky scale. The Journal of Turkish Family
Physician. 2012:17-2026.Holm KE, Plaufcan MR, Ford DW, Sandhaus
RA, Strand M, Strange C, Wamboldt FS.The impact of age on
outcomes in chronic obstructive pulmonary disease differs by
relationship
Downloads
Published
Issue
Section
License
Copyright (c) 2024 International Archives of BioMedical and Clinical Research (IABCR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors are required to sign and submit the completed “Copyright transfer Form” upon acceptance of publication of the paper. This is determined by a publishing agreement between the author and International Archives of Biomedical and Clinical Research. These rights might include the right to publish, communicate and distribute online. Author(s) retain the copyright of their work. International Archives of Biomedical and Clinical Research supports the need for authors to share, disseminate and maximize the impact of their research.